Impact of the COVID-19 Outbreak on the Management of Patients with Cancer
Open Access
- 22 May 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Targeted Oncology
- Vol. 15 (3), 249-259
- https://doi.org/10.1007/s11523-020-00721-1
Abstract
The coronavirus SARS-CoV-2 (COVID-19) outbreak is having a profound impact on the management of patients with cancer. In this review, we comprehensively investigate the various aspects of cancer care during the pandemic, taking advantage of data generated in Asia and Europe at the frontline of the COVID-19 pandemic spread. Cancer wards have been subjected to several modifications to protect patients and healthcare professionals from COVID-19 infection, while attempting to maintain cancer diagnosis, therapy, and research. In this setting, the management of COVID-19 infected patients with cancer is particularly challenging. We also discuss the direct and potential remote impacts of the global pandemic on the mortality of patients with cancer. As such, the indirect impact of the pandemic on the global economy and the potential consequences in terms of cancer mortality are discussed. As the infection is spreading worldwide, we are obtaining more knowledge on the COVID-19 pandemic consequences that are currently impacting and may continue to further challenge cancer care in several countries.This publication has 42 references indexed in Scilit:
- Psychological interventions for people affected by the COVID-19 epidemicThe Lancet Psychiatry, 2020
- Covid-19 — Navigating the UnchartedThe New England Journal of Medicine, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Increased nuclear permeability is a driver for age-related motoneuron lossGeroScience, 2020
- Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 YearsJNCI Journal of the National Cancer Institute, 2019
- Recent declines in cancer incidence: related to the Great Recession?Cancer Causes & Control, 2017
- Managing drug–drug interactions with new direct‐acting antiviral agents in chronic hepatitis CBritish Journal of Clinical Pharmacology, 2016
- Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysisThe Lancet, 2016
- Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patientsBMC Health Services Research, 2011